Current report

Consolidated Balance Sheets

v3.25.2
Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Current Assets      
Cash and cash equivalents $ 746,000 $ 2,338,000 $ 2,815,000
Trading marketable securities   0 7,611,000
Prepaid expenses and other current assets 212,000 219,000 554,000
Deferred offering costs 424,000    
Total Current Assets 1,382,000 2,557,000 10,980,000
Operating lease right-of-use assets 91,000 99,000 21,000
Intangible asset 2,039,000 2,039,000 2,039,000
Other assets 3,000 3,000 3,000
TOTAL ASSETS 3,515,000 4,698,000 13,043,000
Current Liabilities      
Accounts payable and accrued liabilities 2,509,000 1,679,000 1,238,000
Due to related parties 23,000 61,000 30,000
Operating lease liabilities - current portion 36,000 35,000 23,000
Advances from investors 236,000    
Total Current Liabilities 2,804,000 1,772,000 1,291,000
Operating Lease, Liability, Noncurrent 59,000 69,000 0
TOTAL LIABILITIES 2,863,000 1,841,000 1,291,000
STOCKHOLDERS' EQUITY      
Preferred Stock, par value $0.001, 69,445 shares authorized, 0 shares issued and outstanding as of March 31, 2025 and December 31, 2024 0 0 0
Common Stock, par value $0.001, 8,333,333 shares authorized and 567,582 shares issued and outstanding as of March 31, 2025, and December 31, 2024 1,000 1,000 1,000
Additional paid-in capital 53,386,000 53,194,000 52,264,000
Accumulated deficit (52,508,000) (50,136,000) (40,310,000)
Accumulated other comprehensive loss (227,000) (202,000) (203,000)
TOTAL STOCKHOLDERS' EQUITY 652,000 2,857,000 11,752,000
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 3,515,000 $ 4,698,000 $ 13,043,000